FDA inspection
Eli Lilly & Company: FDA inspection ending Jan 13, 2022
FDA inspection 1161160 · Voluntary Action Indicated (VAI) · Indianapolis, IN
Key facts
| Inspection ID | 1161160 |
|---|---|
| Firm | Eli Lilly & Company |
| FEI number | 1819470 |
| Address | 839 S Delaware St |
| City | Indianapolis |
| State | IN |
| ZIP | 46285 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Jan 13, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data